FDA Urges Providers To Work With Registered Compounders

Law360, New York (December 2, 2013, 3:39 PM EST) -- U.S. public health regulators have expanded oversight of drug compounders choosing to register with the U.S. Food and Drug Administration, but the agency will help boost participation despite its voluntary nature by urging hospitals and doctors to work with FDA-registered facilities, FDA officials said Monday.

FDA Commissioner Margaret Hamburg stressed that although it is only voluntary for compounders producing so-called high-risk drugs —  which FDA officials said Monday include sterile medications that are injected into patients — to register with the FDA, the agency will work...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.